Study immune recovery after stem cell or T-cell treatment
Treatments studied
Part of Cancer clinical trials.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be starting an anti-cancer T-cell treatment (like CAR T, TILs, or donor lymphocyte infusion)
- Have a white blood cell count above 100,000 per microliter (a blood test)
- Be able to provide blood and possibly spinal fluid or bone marrow samples around treatment
- If you are in the CAR T group, you must not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
This study looks at how the immune system rebuilds itself after a stem cell transplant. It may help doctors understand recovery better for people with blood cancers or other conditions needing a transplant.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study collects immune and tumor-related samples to learn what predicts response to adoptive cell therapy (a treatment using immune cells). If you (or your child) are eligible, you may help researchers understand who benefits and why.
This study looks at how the immune system recovers after a stem cell transplant for CMML (a type of blood cancer). It aims to understand patients' outcomes over time.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.